103-55-9Relevant articles and documents
CLEAVABLE TETRAZINE USED IN BIO-ORTHOGONAL DRUG ACTIVATION
-
Page/Page column 176-179, (2018/02/03)
Disclosed is an advancement in provoked chemical cleavage. Thereby the invention provides the use of a diene as a chemically cleavable group attached to a Construct, and the use of a dienophile to provoke the release of the Construct by allowing the diene to react with a dienophile capable of undergoing an inverse electron demand Diels Alder reaction with the diene. The invention includes a kit for releasing a Construct CA bound to a Trigger TR, the kit comprising a tetrazine and a dienophile, wherein the Trigger is the tetrazine. The invention also includes the use of the formation of a pyridazine by reacting a tetrazine comprising a Construct CA bound thereto and a dienophile, as a chemical tool for the release, in a chemical, biological or physiological environment, of said Construct.
Benzenesulfonamide derivatives and their use as MEK inhibitors
-
, (2008/06/13)
Benzenesulfonamides of formula (I), in which W is OR1, NR2OR1, NRARB, NR2NRARB, or NR2(CH2)2-4NRARBand the other variables as defined in the claims, are inhibitors of MEK and are effective in the treatment of proliferative diseases, cancer, stroke, heart failure, xenograft rejection, arthritis, cystic fibrosis, hepatomegaly, cardiomegaly, Alzheimer's disease, complications of diabetes, septic shock, and viral infection.
Cu(II) CATALIZED HYDROLYSIS OF AN UNACTIVATED ESTER BASED ON REVERSIBLE CONJUGATE ADDITION.
Duerr, Brook F.,Czarnik, Anthony W.
, p. 6951 - 6954 (2007/10/02)
Cu(II) catalysis provides a 16,000-fold acceleration in the hydrolysis of methyl acrylate when a removable vicinal diamine ligand is used to increase the stability of the required copper chelate.